# Cambridge Cognition Positive pipeline provides ‘Big wins for the business’ (Interview)

- Link: https://www.directorstalkinterviews.com/cambridge-cognition-positive-pipeline-provides-big-wins-for-the-business-interview/412825983
- Published: 2020-05-28T09:14:57+01:00
- Author: Giles Arbor

**Cambridge Cognition Holdings plc** ([LON:COG](https://www.directorstalkinterviews.com/company/cambridge-cognition-holdings-plc/cog.l))
CEO Matthew Stork joins DirectorsTalk to discuss winning increasing numbers of virtual
clinical trials during COVID-19. Matthew talks us through the wins and explains 
what the company will be providing, the benefits of using virtual or part virtual
assessments, using these kind of trials after COVID-19 and what we can expect to
see from the company in the future.

Cambridge Cognition is a neuroscience technology company developing digital health
products to better understand, detect and treat conditions affecting brain health.
The company’s software products assess cognitive health in patients worldwide to
improve clinical trial outcomes, identify and stratify patients early and improve
global efficiency in pharmaceutical and healthcare industries.

Share on: